This is a pivotal step toward eliminating the trial and error approach from breast cancer patients treatment. FARMINGTON, Conn. (PRWEB) December 05, 2017 Bioarray Genetics, Inc. ("Bioarray" or the "Company") announced today that the Company will be presenting a pivotal study at the upcoming 40th Annual San Antonio Breast Cancer Symposium on December 7th. [...]